Since Tuesday evening, the online platform www.kl.ac.at/coronavirus has been offering secure, up-to-date and well-founded recommendations for action for doctors in private practice. These recommendations are made available by doctors for doctors after prior review, analysis and daily updates. The new information platform recorded more than 15,000 hits in the first 24 hours.

The application deadline for the Bachelor Programme Health Sciences, which is the first part of the bologna-compliant medical studies programme, has been extended.

Researchers from the Karl Landsteiner University aim to develop a novel model of bone metastatic disease in breast cancer. A new project just launched aims at gaining insights into the development of bone metastases in breast cancer patients and identifying biomarkers as well as new treatment strategies.

Major worldwide research project discovers that 71% of women are unhappy with their breast size. The resulting reduced breast awareness might influence cancer detection by self-examination.

The second event of the Maimonides Lectures in Lower Austria "Psyche. Health, Disease and Healing in the Frame of Reference of the Abrahamic Religions", the 10th of the entire series of Maimonides Lectures scientifically led by Prof. Dr. Patrizia Giampieri-Deutsch and Prof. Dr. Hans-Dieter Klein, took place on Wednesday 27th and Thursday 28th November 2019 in the ballroom of the Karl Landsteiner Private University for Health Sciences in Krems an der Donau.

We would like to take this opportunity to say goodbye to you for the Christmas holidays.

A novel agent called Selinexor has opened up new options for the treatment of patients with refractory myeloma. This was the conclusion of a major international clinical trial in which also the Karl Landsteiner University of Health Sciences in Krems, Austria (KL Krems) participated. The results have now been published in the New England Journal of Medicine. Thanks to a new mode of action, the compound brings hope to the growing number of patients whose tumor cells have become resistant to the three backbone drug classes.

On Wednesday, 25.9.2019, a delegation of ACMIT - Austrian Center for Medical Innovation and Technology, honoured the Karl Landsteiner University of Health Sciences (KL) during a company outing.

On Monday, September 16th 2019, the Seaman Award was awarded for the first time to five medical graduates for their outstanding Master's theses at their academic ceremony.

On Thursday, September 12, 2019, the closing event of the Life Science project "The role of phage in antibiotic resistance" took place at the University Hospital St. Pölten. During the one-day conference international scientists discussed the results of almost four years of research. Karl Landsteiner University of Health Sciences was part oft he research project.

The ESB Conference will take place this year from 7-10 July for the 25th time, the first time in Vienna. The Karl Landsteiner University of Health Sciences is a member of the Organizing Committee together with the Vienna University of Technology and the European Society of Biomechanics. Around 750 participants from more than 30 nations will take part in the conference.

At its meeting on 3 July 2019, the KL General Assembly reappointed Rudolf Mallinger as Rector and Sabine Siegl as Prorector for the term of office from 1 February 2020 to 31 January 2026.